Global HIV Treatment Gap Leaves 8.8 Million Behind
Global HIV treatment gap leaves 8.8 million people without therapy as funding cuts weaken testing, prevention and community-led services.
Lenacapavir PrEP Rollout Brings Hope Amid Service Cuts
The Lenacapavir PrEP Rollout offers six-month HIV protection, but aid cuts and clinic access gaps raise concerns for high-risk groups.
Lenacapavir HIV Prevention Injection: SA Rollout Faces Heat
The lenacapavir HIV Prevention Injection rollout begins in SA, but activists warn that limited supply from Gilead could blunt the impact.